Sato Pharmaceutical Recalls INON ACE Antacid Tablets for Disintegration Issues
Sato Pharmaceutical Co., Ltd. recalled 3,640 bottles of INON ACE Antacid tablets on December 19, 2025. The recall follows failed disintegration specifications, indicating the tablets may not dissolve properly. Consumers should stop using the product immediately and seek guidance from healthcare providers.
About This Product
INON ACE Antacid tablets are designed to provide relief from symptoms of heartburn and indigestion. Consumers typically purchase antacids for quick relief from gastrointestinal discomfort.
Why This Is Dangerous
The recall stems from the product failing to meet disintegration specifications, which means the tablets may not dissolve as intended in the digestive system. This can lead to inadequate symptom relief for users.
Industry Context
This recall is not part of a broader industry pattern.
Real-World Impact
Consumers relying on these antacid tablets may experience a lack of effective relief from symptoms, potentially leading to discomfort or worsening of symptoms.